DiaMedica Therapeutics Inc
DMAC
Get informed when a big investor buys or sells
+ FollowMarket Cap$363.71M
Close$
$0.33
95.1% downside
Current Fair Value
95.1% downsideOvervalued by 95.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $363.71 Million |
|---|---|
| Enterprise Value | $359.06 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.7 |
| Beta | 0.97 |
| Outstanding Shares | 53,793,490 |
Return
| Return on Equity | -74.31% |
|---|---|
| Return on Assets | -66.13% |
| Return on Invested Capital | -54.80% |
Valuation & Multiples
| P/E Ratio | -9.51 |
|---|---|
| PEG | -31.38 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -13.84 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-0.20
Average shareholder expectationRevenue Estimate
$13.50 M
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-0.20
Average shareholder expectationRevenue Estimate
$13.50 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 74.32% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 6.96%▼ 14.79% |
|---|---|
| Total Invested | $26.36M▼ 66.70% |
| Investors Holding | 30▼ 71.00% |
ESG Score
No data